HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 1487532, compound → HCID 68408078, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 1487532 | HCID 1487532 | — |
| Reactant | N-(2-t-Butoxycarbonylaminophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | HCID 59830883 | — |
| Product | HCID 68408078 | HCID 68408078 | 110% |
Reaction Steps
Using an analogous procedure to that described in Method 44, N-(2-t-butoxycarbonylaminophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (Method 13, 219 mg, 0.5 mmol) was reacted with 1-[(2-chloro-1,3-thiazol-5-yl)methyl]piperidine (108 mg, 0.5 mmol) to give the title compound (271 mg, >100%) which was carried through the next step; Mass Spectrum: M+H+ 493.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08247562B2 |
| Source dataset | uspto-grants-2012_08 |
| ORD ID | ord-2c6d0f965d0947f289d813182d83ec96 |
| Source note | uspto-grants-2012_08 |